New vaccines for RSV and bird flu enter human testing
NCT ID NCT07516418
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial is testing several new vaccine formulas against RSV and H5N1 bird flu in 570 healthy adults aged 18 to 49. The main goals are to check safety and see how well the vaccines trigger an immune response. Participants will receive one or two shots and be followed for about 6 to 7 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- RSV and H5 flu vaccines
- What this could lead to
- If successful, this could lead to new vaccines that protect against RSV and H5N1 bird flu.
- What could go wrong
- This is an early Phase 1 trial focused on safety, so it is too soon to know if the vaccines will work. Side effects are possible, and the results may not apply to older or younger people.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A(H5N1) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Site # 036006
RECRUITINGTaringa, Queensland, 4068, Australia
-
Site # 03610004
RECRUITINGSouth Brisbane, Queensland, 4104, Australia
-
Site # 0361001
RECRUITINGHerston, Queensland, 4006, Australia
-
Site # 0361002
RECRUITINGGriffith, Queensland, 4222, Australia
-
Site # 0361003
RECRUITINGMorayfield, Queensland, 4506, Australia
-
Site # 0361005
RECRUITINGSippy Downs, Queensland, 4556, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One shot, two viruses? new mRNA vaccine targets RSV and hMPV
- New mRNA vaccine aims to shield against RSV
- Massive RSV vaccine study uses real-world data to see if shots prevent severe illness
- New RSV vaccine aims to shield adults from severe respiratory infection
- Scientists test RSV vaccine to boost immune memory
- New study tracks RSV in pregnant women and their babies